Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiomics Insight Into the Role of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure

28 Apr 2025

Abstract excerpt

Abstract Aims Cardiovascular diseases, such as atrial fibrillation, coronary artery disease, heart failure (HF) and ischaemic stroke, are leading causes of death globally and exert major global health burden. Recent studies suggest that glucagon-like peptide-1 receptor agonists (GLP1Ra), a novel class of antidiabetic drugs, may not only help manage blood glucose but also reduce the risks of cardiovascular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines, Inflammation, and Metabolic Diseases
Share to Diabetes Treatment and Management
Share to Fibroblast Growth Factor Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40290076
DOI: 10.1002/ehf2.15310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiomics Insight Into the Role of Glucagon-Like Peptide-1 Receptor Agonists in Heart FailurePMID 40290076Read ↗

The Cardiovascular Physiology of Glucagon-like Peptide-1 Receptor Agonists: From Macro-level Outcomes to Micro-level MechanismsSemantic proximity Read ↗

Independent and Inflammation-Linked Contribution of Fasting Plasma Glucose to Heart Failure Risk in Chronic Non-Rheumatic Aortic RegurgitationSemantic proximity Read ↗

Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis.Semantic proximity Read ↗

Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk.Semantic proximity Read ↗

Role of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) in Patients with Chronic Heart FailureSemantic proximity Read ↗

Genetic Evidence for Repurposing of GLP1R (Glucagon-Like Peptide-1 Receptor) Agonists to Prevent Heart Failure.Semantic proximity Read ↗

Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization.Semantic proximity Read ↗

ASGR1 inhibitors, inflammation, and heart failure: A Mendelian randomization analysis.Semantic proximity Read ↗

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.Semantic proximity Read ↗

Heart Failure in the Molecular Era: Redefining Our Understanding of Disease Mechanisms and PerspectivesSemantic proximity Read ↗

The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity Read ↗

A New Perspective in Hypertensive Heart Disease: From Epidemiology to Molecular and Metabolic Inflammation InsightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.